B6.Cg-Cyldtm1.2Gmos/Flmg

Status

Available to order

EMMA IDEM:10968
Citation informationRRID:IMSR_EM:10968 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.Cg-Cyldtm1.2Gmos/Flmg
Alternative nameB6-Cyld/Flmg
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolCyldtm1.2Gmos
Gene/Transgene symbolCyld

Information from provider

ProviderGeorge Mosialos
Provider affiliationBSRC Al. Fleming
Genetic informationGerm line, cre mediated recombination removed the neomycin cassette upstream of exon 9. Exon 9 of the mouse Cyld gene is flanked by loxP sites. This exon codes for an essential catalytic motif of the deubiquitination domain.
Phenotypic informationHomozygous:
No overt phenotype.

Heterozygous:
No overt phenotype
Breeding historyBackcrossed to C57BL/6 for at least 10 generations.
References
  • Truncation of the catalytic domain of the cylindromatosis tumor suppressor impairs lung maturation.;Trompouki Eirini, Tsagaratou Ageliki, Kosmidis Stylianos K, Dollé Pascal, Qian Jun, Kontoyiannis Dimitris L, Cardoso Wellington V, Mosialos George, ;2009;Neoplasia (New York, N.Y.);11;469-76; 19412431
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreB.S.R.C. Alexander Fleming, Vari, Greece
Animals used for archivingheterozygous C57BL/6 males, wild-type C57BL/6J females
Stage of embryosMorula

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • increased eosinophil cell number / IMPC
  • increased basophil cell number / IMPC
  • decreased locomotor activity / IMPC
  • increased grip strength / IMPC
  • decreased exploration in new environment / IMPC
MGI phenotypes (gene matching)
  • abnormal circulating serum albumin level / MGI
  • increased cell proliferation / MGI
  • abnormal intestinal epithelium morphology / MGI
  • abnormal colon morphology / MGI
  • kinked tail / MGI
  • short tail / MGI
  • abnormal spleen morphology / MGI
  • enlarged spleen / MGI
  • enlarged lymph nodes / MGI
  • thymus hyperplasia / MGI
  • abnormal lung development / MGI
  • atelectasis / MGI
  • epidermal hyperplasia / MGI
  • weight loss / MGI
  • hunched posture / MGI
  • cyanosis / MGI
  • abnormal humoral immune response / MGI
  • decreased IgM level / MGI
  • abnormal inflammatory response / MGI
  • increased skin papilloma incidence / MGI
  • premature death / MGI
  • abnormal B cell differentiation / MGI
  • no abnormal phenotype detected / MGI
  • abnormal lung interstitium morphology / MGI
  • abnormal respiratory function / MGI
  • abnormal spleen marginal zone morphology / MGI
  • abnormal Peyer's patch germinal center morphology / MGI
  • decreased susceptibility to bacterial infection / MGI
  • abnormal B cell physiology / MGI
  • increased IgA level / MGI
  • gastric ulcer / MGI
  • small lung / MGI
  • increased incidence of tumors by chemical induction / MGI
  • abnormal class switch recombination / MGI
  • abnormal B cell morphology / MGI
  • decreased B-1 B cell number / MGI
  • increased B cell number / MGI
  • increased double-positive T cell number / MGI
  • immune system phenotype / MGI
  • abnormal enzyme/coenzyme activity / MGI
  • abnormal T cell number / MGI
  • decreased CD4-positive, alpha beta T cell number / MGI
  • decreased CD8-positive, alpha-beta T cell number / MGI
  • enlarged Peyer's patches / MGI
  • increased follicular B cell number / MGI
  • increased marginal zone B cell number / MGI
  • increased pro-B cell number / MGI
  • decreased immature B cell number / MGI
  • decreased IgG3 level / MGI
  • increased IgG1 level / MGI
  • increased IgG2a level / MGI
  • increased IgG2b level / MGI
  • increased susceptibility to induced colitis / MGI
  • abnormal keratinocyte proliferation / MGI
  • increased keratinocyte proliferation / MGI
  • decreased birth body size / MGI
  • decreased susceptibility to bacterial infection induced morbidity/mortality / MGI
  • neonatal lethality, complete penetrance / MGI
  • thick lung-associated mesenchyme / MGI
  • impaired fibroblast cell migration / MGI

Literature references

  • Truncation of the catalytic domain of the cylindromatosis tumor suppressor impairs lung maturation.;Trompouki Eirini, Tsagaratou Ageliki, Kosmidis Stylianos K, Dollé Pascal, Qian Jun, Kontoyiannis Dimitris L, Cardoso Wellington V, Mosialos George, ;2009;Neoplasia (New York, N.Y.);11;469-76; 19412431

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).